CYTOF on OTC

Altamira Therapeutics Ltd.

Price unavailable

Last updated Oct 16, 2026.

Overview

-$8.5MNet income, fiscal 20242

Compare with AC Immune SA or MindMaze Therapeutics Holding SA, or pick any stock.

  • TickerCYTOF on OTC
  • IndustryPharmaceutical Preparations
  • HeadquartersD0
  • Incorporated inBermuda3
  • Business addressClarendon House, 2 Church Street, Hamilton Hm 11, D0 000003
  • Filer categoryNon-accelerated filer3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in CHF, the currency the company reports in.

Key numbers, fiscal 2022

-372.4%Gross margin4
-6172.0%Operating margin2
-9089.3%Net margin2
378.4%Revenue growth, 20224

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Other costs100¢305.6K CHF

Out of 305.6K CHF in revenue.42 The company lost money this year.

Financial statements

Revenue4305.6K CHF in 2022+378% since 2021
0100.0K CHF200.0K CHF300.0K CHF400.0K CHF2021: 63.9K CHF63.9K CHF20212022: 305.6K CHF305.6K CHF2022+378%
Gross profit4-1.1M CHF in 2022−48% since 2021
-3.0M CHF-2.0M CHF-1.0M CHF02021: -2.2M CHF-2.2M CHF20212022: -1.1M CHF-1.1M CHF2022−48%
Net income52-27.8M CHF in 2022+142% since 2018
-30.0M CHF-20.0M CHF-10.0M CHF02018: -11.5M CHF-11.5M CHF20182019: -6.6M CHF-6.6M CHF2019−42%2020: -8.2M CHF-8.2M CHF2020+24%2022: -27.8M CHF-27.8M CHF2022+239%
Fiscal year201720182019202020212022
Revenue63.9K CHF4305.6K CHF4
Gross profit-2.2M CHF4-1.1M CHF4
Research and development19.2M CHF66.7M CHF53.3M CHF52.9M CHF5
Operating income-$18.9M2
Net income-11.5M CHF5-6.6M CHF5-8.2M CHF5-$27.8M2
Earnings per share-$610.032
Earnings per share (diluted)-$610.032

Compare Altamira Therapeutics Ltd. with another company

Former names

  • Auris Medical Holding Ltd.Feb 11, 2019 to Jul 23, 20213
  • Auris Medical Holding AGApr 15, 2014 to Mar 14, 20193
  • Auris Medical AGMar 18, 2014 to Apr 18, 20143

Recent filings

  1. Feb 27, 202615-12G FORM 15-12B
  2. Aug 29, 20256-K REPORT OF FOREIGN PRIVATE ISSUER
  3. Jun 17, 202525-NSE
  4. Jun 11, 20256-K
  5. May 15, 2025SCHEDULE 13G/A
  6. May 9, 20256-K REPORT OF FOREIGN PRIVATE ISSUER
  7. May 6, 2025SCHEDULE 13D/A
  8. Apr 30, 20256-K REPORT OF FOREIGN PRIVATE ISSUER
  9. Apr 30, 202520-F ANNUAL REPORT
  10. Apr 4, 2025S-8 REGISTRATION STATEMENT
  11. Mar 10, 20256-K REPORT OF FOREIGN PRIVATE ISSUER
  12. Feb 14, 2025SCHEDULE 13G/A
  13. Dec 20, 20246-K REPORT OF FOREIGN PRIVATE ISSUER
  14. Nov 14, 2024SC 13G
  15. Oct 4, 20246-K REPORT OF FOREIGN PRIVATE ISSUER

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9